OmniAb Cash Flow Statement
NASDAQ: OABIHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
4.79+0.13 (+2.79%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
OmniAb free cash flow
In fiscal 2025, OmniAb generated -$36.5 million of operating cash flow and spent $565,000 on capital expenditures. That left free cash flow of -$37.0 million, a free-cash-flow margin of -198.3% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
OmniAb cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 |
|---|---|---|---|---|---|
| Net Income | -64.78M | -62.03M | -50.62M | -22.33M | -27.04M |
| Net Income growth (YoY) | — | — | — | — | — |
| Depreciation & Amortization | 21.75M | 23.58M | 19.50M | 18.25M | 16.25M |
| Stock-Based Compensation | 15.82M | 21.50M | 24.82M | 18.32M | 15.06M |
| Change in Working Capital | -2.75M | -8.38M | 24.79M | -11.87M | 183.00K |
| Operating Cash Flow | -36.45M | -39.66M | 2.35M | -3.59M | -5.67M |
| Capital Expenditures | -565.00K | -1.88M | -1.64M | -17.17M | -4.07M |
| Investing Cash Flow | 6.47M | 37.88M | -18.38M | -73.31M | -4.03M |
| Financing Cash Flow | 27.91M | 13.02M | -892.00K | 110.74M | 9.70M |
| Net Change in Cash | -2.07M | 11.24M | -16.92M | 33.84M | 0 |
| Free Cash Flow | -37.02M | -41.54M | 703.00K | -20.75M | -9.74M |
This table shows 5 annual periods of OmniAb's cash flow statement, from FY 2025 back to FY 2021, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OABI's reporting calendar. What is a cash flow statement?